Separation of phospholipids by high-performance liquid chromatography: all major classes, including ethanolamine and choline plasmalogens, and most minor classes, including lysophosphatidylethanolamine

High-performance liquid chromatographic methods for the separation and quantitation of phospholipids were developed and shown to give sensitive, reliable measurements of tissue phospholipids, including difficult-to-resolve pairs such as choline plasmalogen (plasmenylcholine) and phosphatidylcholine, choline glycerophospholipids and sphingomyelin, phosphatidylinositol and phosphatidylserine, and phosphatidylserine and lysophosphatidylethanolamine. Separations of most phospholipids including those mentioned above are more complete than in existing procedures, and require only 40 min per injection. Utilization of the hexane-2-propanol-water system has an advantage over separation techniques that employ acidic solvents in that the plasmalogens are not hydrolyzed and a less degradative environment for labile lipids is provided. Further, a rapid high-performance liquid chromatographic procedure for the separation of intact ethanolamine plasmalogen (plasmenylethanolamine) from phosphatidylethanolamine was developed. Previous procedures have required derivatized samples or acid hydrolysis of the plasmalogen vinyl ether linkage. A slight modification of the primary method (method I) increases the resolution of lysophosphatidylethanolamine from other classes (method II). A third modification (method III) can replace the standard silicic acid column separation of lipids into neutral, glycolipid, and phospholipid fractions.     

Evaluation of high-performance liquid chromatography column retentivity using macromolecular probes. II. Silanophilic interactivity traced by highly polar polymers

A new method of HPLC column retentivity testing utilizes polymeric probes instead of conventional sets of low molar mass substances. The procedure allows at least semiquantitative, separate and independent evaluation of adsorption and partition properties of column packings. In this present work, the method is applied for comparison of the polar interactivities of selected silica gel C18 HPLC columns. It is shown that free silanols which remained on the surface of the end-capped silica C18 column packings are accessible for interaction with highly polar macromolecules. High molar mass polymeric test probes are adsorbed on the surface silanols and their retention volumes increase. As result, deviations from regular size-exclusion chromatographic (SEC) behavior are observed. The extent of retention volume changes depends on both the nature of polymer probes and on column packing type. Adsorption of macromolecules can be suppressed by addition of a highly polar substance to the mobile phase. The amount of polar additive which is needed to attain regular SEC elution of the polymer probe depends on the column packing type and can be used as a characteristic of silanophilic column interactivity. Courses of dependences of retention volumes on sizes of macromolecules indicate the presence of "U-turn" adsorption which allows two and more silanols situated among C18 groups to be occupied simultaneously with the same macromolecule.     

Liquid-crystalline phase behavior of a colloidal rod-plate mixture

The phase behavior of rod-plate mixtures was investigated using model systems containing unambiguously rod- and plate-shaped colloids. We find that the theoretically disputed biaxial nematic phase is unstable with respect to demixing into an isotropic and two uniaxial nematic phases. The phase behavior at very high densities is exceptionally rich and includes the coexistence of up to four different liquid crystalline phases, which stem from the coupling between the employed particle shapes and polydispersity.     

<Emphasis Type="Italic">parkin</Emphasis> counteracts symptoms in a <Emphasis Type="Italic">Drosophila</Emphasis> model of Parkinson's disease

Background

Parkinson's disease, a prevalent neurodegenerative disease, is characterized by the reduction of dopaminergic neurons resulting in the loss of motor control, resting tremor, the formation of neuronal inclusions and ultimately premature death. Two inherited forms of PD have been linked to mutations in the α-synuclein and parkin genes. The parkin protein functions as an ubiquitin ligase targeting specific proteins for degradation. Expression of human α-synuclein in Drosophila neurons recapitulates the loss of motor control, the development of neuronal inclusions, degeneration of dopaminergic neurons and the ommatidial array to provide an excellent genetic model of PD.

Results

To investigate the role of parkin, we have generated transgenic Drosophila that conditionally express parkin under the control of the yeast UAS enhancer. While expression of parkin has little consequence, co-expression of parkin with α-synuclein in the dopaminergic neurons suppresses the α-synuclein-induced premature loss of climbing ability. In addition directed expression of parkin in the eye counteracts the α-synuclein-induced degeneration of the ommatidial array. These results show that parkin suppresses the PD-like symptoms observed in the α-synuclein-dependent Drosophila model of PD.

Conclusion

The highly conserved parkin E3 ubiquitin ligase can suppress the damaging effects of human α-synuclein. These results are consistent with a role for parkin in targeting α-synuclein to the proteasome. If this relationship is conserved in humans, this suggests that up-regulation of parkin should suppress α-synucleinopathic PD. The development of therapies that regulate parkin activity may be crucial in the treatment of PD.

     

Pressure broadening of the oxygen λ5577 Å line by rare gas

We report on measurements of collision broadening of the electric quadrupole transition λ5577.35 Å in oxygen by argon, krypton and xenon. The broadening constant (linewidth added per unit atom density) was found to be: (4.3 ± 2.3) × 10^-21 cm^-1 atom^-1 cm³ for argon (reported earlier), (8.0 ± 1.7) × 10^-21 cm^-1 atom^-1 cm³ for krypton, and (10.0 ± 2.0) × 10^-21 cm^-1 atom^-1 cm³ for xenon. We discuss some experimental problems associated with these measurements.